Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 12, 2021

SELL
$81.78 - $95.14 $343,312 - $399,397
-4,198 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$85.24 - $94.15 $357,837 - $395,241
4,198 New
4,198 $383,000
Q4 2020

Jan 13, 2021

SELL
$78.07 - $94.43 $254,664 - $308,030
-3,262 Closed
0 $0
Q3 2020

Oct 09, 2020

BUY
$82.14 - $91.0 $267,940 - $296,842
3,262 New
3,262 $284,000
Q2 2020

Jul 08, 2020

SELL
$80.93 - $91.1 $267,230 - $300,812
-3,302 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$70.67 - $99.01 $233,352 - $326,931
3,302 New
3,302 $270,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Symphony Financial, Ltd. Co. Portfolio

Follow Symphony Financial, Ltd. Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

News

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.